In lupus, RA and spondyloarthritis, associations were found of ICOS expression by Tregs with high disease activity, with non-response to therapy, increased autoantibodies, and pro-inflammatory cytokine production31,37–39. This evidence concerns the gene ICOS and spondyloarthropathy.